Viewing Study NCT06653530



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06653530
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-21

Brief Title: Thread Embedding Acupuncture Therapy for Weight Loss
Sponsor: None
Organization: None

Study Overview

Official Title: Efficacy and Safety of Thread Embedding Acupuncture Therapy for Weight Loss in Adults with Overweight or Obesity
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: iSho
Brief Summary: Obesity is the most prevalent chronic disease worldwide affecting approximately 800 million adults Excess adiposity and its numerous complications including cardiovascular disease and type 2 diabetes impose a considerable economic burden and constitute major contributors to global morbidity and mortality Treatments that result in substantial weight reductions may improve outcomes for people living with obesity Thread embedding acupuncture which provides long-term acupoints stimulation may be an effective treatment option for obesity However effects of thread embedding on obesity remain uncertain because of the small sample sizes or other methodological limitations The objective of this multi-center randomized sham-controlled trial is to assess the effect of thread embedding acupuncture for alleviating weight
Detailed Description: The present multi-center randomized sham-controlled parallel-group trial aims to evaluate the effect of thread embedding acupuncture in patients with obesity

The patients will be randomized to receive one of two treatment arms thread embedding acupuncture and sham thread embedding acupuncture The participants will receive treatment that consists of 18 thread embedding acupuncture or sham thread embedding acupuncture sessions over a 24-week period after baseline once a week for the first 12 weeks and every two weeks for the next 12 weeks At the end of 24 weeks treatment the change of weight in overweightobese participants between the two groups will be analyzed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None